Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


Fluoxetine- and sertraline-related hair loss in a teenager: a case report

Serhat Turkoglu.

Cited by (1)

Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed antidepressants. All SSRIs have occasionally been associated with alopecia or hair loss. There might be differences in the risk of alopecia between the various SSRIs, and the risk might be higher in women than in men. The pathological mechanism of hair loss due to psychotropic medications has not yet been fully elucidated. Here, we present an adolescent female with no personal and family history of alopecia, who developed common alopecia with consecutive fluoxetine and sertraline treatments. The hair loss stopped with a venlafaxine regimen. To our knowledge, this is the first report of hair loss due to both fluoxetine and sertraline, which then recovered with venlafaxine treatment. If a patient develops hair loss during SSRI treatment and the temporal relationship seems plausible, an adverse drug reaction should be suspected and changing the treatment to another antidepressant or possibly decreasing the dose should be considered.

Key words: Fluoxetine, sertraline, alopecia, side effects

Share this Article

American Journal of Physiology, Biochemistry and Pharmacology


ScopeMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons